Drug details

Pulmozyme (dornase alfa)

type of Enzymes, Mucolytic

Pulmozyme (dornase alfa) Inhalation Solution is a synthetic protein used to improve lung function in people with cystic fibrosis by thinning pulmonary secretions and reducing the risk of respiratory tract infections.

The drug is often used to treat Cystic fibrosis .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• fever
• chest pain, and
• increased difficulty breathing,

The following drugs are related to Pulmozyme, either as a replacement or used together:

• Bethkis (tobramycin inhalation solution)
• Kalydeco (ivacaftor)
• Kitabis Pak (tobramycin inhalation solution for oral inhalation)
• Trikafta (lexacaftor, tezacaftor and ivacaftor tablets; ivacaftor tablets)
• Pancreaze (pancrelipase microtablets)
• Ultresa (pancrelipase)
• Pertzye (pancrelipase)
• Zenpep (pancrelipase delayed release capsules)
• Tobi (tobramycin)
• TOBI Podhaler (tobramycin inhalation powder)